A new study sparks a war of words over the drug industry’s commitment to research
ALEX HOGAN/STAT
A coalition of drug industry foes is pointing to a new study that finds drug makers spent about 22% of their revenues on research in 2017.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario